The Jackson Laboratory (JAX) is committed to helping address the coronavirus (COVID-19) outbreak as rapidly as possible. The Jackson Laboratory for Genomic Medicine, located in Farmington, Connecticut, is partnering with hospitals and health care facilities in Connecticut and Maine with additional coronavirus testing capacity for symptomatic frontline health care workers and in-patients.
We are actively utilizing our expertise in genomic solutions and our Connecticut-licensed CLIA (Clinical Laboratory Improvement Amendments) and CAP-accredited laboratory to test patient samples for a specific RNA signature unique to SARS-CoV-2, the virus that causes COVID-19.
The Jackson Laboratory is also establishing a COVID-19 Biorepository to store existing clinical samples and data and to prospectively collect specimens and data from individuals tested for COVID-19 at the JAX CLIA Laboratory. This will enable JAX scientists and their collaborators at other institutions to study the materials stored in the biorepository to better understand and find new ways to detect, treat, and/or prevent COVID-19. It is our hope that some of these studies may lead to new products, such as vaccines, drugs or tests for the disease.
A biorepository is a “bank” that collects, processes, stores, and distributes biospecimens and information to researchers. Scientists can then study the materials stored in the JAX COVID-19 Biorepository to understand this new coronavirus to find ways to detect, treat, and perhaps prevent COVID-19.
Individuals who have had a sample tested for COVID-19 at the JAX CLIA Laboratory.
The Principal Investigator (PI) of the JAX COVID-19 Biorepository project is Dr. Charles Lee, Scientific Director of The Jackson Laboratory for Genomic Medicine. Other researchers at JAX may apply to access samples and data.
You will provide consent to allow use of the leftover samples that your doctor/hospital sent to the Jackson Laboratory CLIA Laboratory for COVID-19 testing and permission to access your test results.
Your leftover samples will be involved in DNA and RNA studies.
DNA is in your blood and other samples. Genes are made of DNA. Our hair color, eye color, and risk for some diseases depend on our genes.
RNA is the way that the genes tell the cells in the body what to do.
The data coming from these analyses will be labeled with a code instead of your name and securely shared in online scientific databases. Researchers will have to apply to the database with a scientific project to be able to access the coded data.
You will be asked to complete questionnaires about you, your test results, your exposure to COVID-19, your symptoms, your health history and medication. If you were in the hospital, we might ask you for the permission to have access to your hospital records.
You will be given the option to be contacted for future samples (blood samples, swabs from your mouth or skin), and to participate in additional research projects. You don’t have to say yes to future studies in order to be part of the JAX COVID-19 Biorepository.
Researchers who study your sample and information will not know who you are. Coded samples and data may be shared with JAX researchers and approved collaborators but no information that could identify you will be shared.
Federal privacy rules require appropriate safeguards for privacy, security, and authorized access to personally identifiable information. We will not give information that identifies you to anyone without your permission, except if required by law.
If you are interested in taking part of the JAX COVID-19 Biorepository, you will complete an online screening form to make sure you fit the criteria of the biorepository. You will then be asked to select how you would like to review and provide informed consent. This may be done online or over the phone with a study team member.
You are free to change your mind about participation in the JAX COVID-19 Biorepository at any time. If you change your mind, please contact us at 860-837-2404.